Efficacy News and Research

RSS
Unsuccessful drug against anxiety opens a novel gateway for the treatment of cancer

Unsuccessful drug against anxiety opens a novel gateway for the treatment of cancer

Celgene receives FDA 'fast track' for Amrubicin in small cell lung cancer after first-line chemotherapy

Celgene receives FDA 'fast track' for Amrubicin in small cell lung cancer after first-line chemotherapy

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma

Anadis to commercialise "BioGard" adjunctive therapy for HIV/AIDS

Anadis to commercialise "BioGard" adjunctive therapy for HIV/AIDS

Second phase 3 trial of Bronchitol in cystic fibrosis sufferers begins

Second phase 3 trial of Bronchitol in cystic fibrosis sufferers begins

Clinical trial advances cystic fibrosis therapy

Clinical trial advances cystic fibrosis therapy

Panacea Pharmaceuticals issued U.S. patent for anti-HAAH antibodies

Panacea Pharmaceuticals issued U.S. patent for anti-HAAH antibodies

Diffusion Pharmaceuticals initiates phase I/II clinical trial in patients with peripheral arterial disease

Diffusion Pharmaceuticals initiates phase I/II clinical trial in patients with peripheral arterial disease

Vimpat (lacosamide) approved in Europe

Vimpat (lacosamide) approved in Europe

Alte Biosciences files patent for novel inflammatory bowel disease drugs

Alte Biosciences files patent for novel inflammatory bowel disease drugs

FDA authorizes INDA for recombinant human C1 inhibitor in kidney transplantation

FDA authorizes INDA for recombinant human C1 inhibitor in kidney transplantation

New guidelines for dealing with earwax

New guidelines for dealing with earwax

Fibrex medical reports positive phase II results for peptide for the treatment of reperfusion injury

Fibrex medical reports positive phase II results for peptide for the treatment of reperfusion injury

First patient enrolled in study evaluating S.M.A.R.T. Nitinol self-expandable stent

First patient enrolled in study evaluating S.M.A.R.T. Nitinol self-expandable stent

Overcoming poor response to standard oral antiplatelet agents

Overcoming poor response to standard oral antiplatelet agents

Results from the Simvastatin and Ezetimibe in aortic stenosis study

Results from the Simvastatin and Ezetimibe in aortic stenosis study

MorphoSys announces publication of first MOR103 data

MorphoSys announces publication of first MOR103 data

Earwax removal - new guidelines

Earwax removal - new guidelines

Advances in the management of diabetes mellitus

Advances in the management of diabetes mellitus

Antiangiogenic and anti-inflammatory drugs: are they safe?

Antiangiogenic and anti-inflammatory drugs: are they safe?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.